301331 恩威醫藥
按盤價 
22.530 -0.150 (-0.661%)
22.530 -0.150 (-0.661%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.772 | 7.651 | 7.553 | 16.559 | 19.916 |
| 總資產報酬率 ROA (%) | 0.626 | 6.292 | 5.960 | 11.844 | 12.363 |
| 投入資產回報率 ROIC (%) | 0.739 | 7.430 | 7.280 | 15.888 | 19.092 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.261 | 51.255 | 50.196 | 56.342 | 57.462 |
| 營業利潤率 (%) | 5.719 | 12.956 | 11.842 | 17.534 | 19.610 |
| 息稅前利潤/營業總收入 (%) | 5.497 | 12.087 | 11.644 | 17.635 | 19.849 |
| 淨利潤/營業總收入 (%) | 4.591 | 10.993 | 9.804 | 14.968 | 16.586 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.200 | 85.739 | 86.845 | 83.429 | 81.702 |
| 價值變動淨收益/利潤總額(%) | 10.077 | 3.694 | 0.721 | -0.366 | 0.007 |
| 營業外收支淨額/利潤總額(%) | -0.005 | -0.407 | -0.041 | -0.043 | 0.093 | 償債能力分析 |
| 流動比率 (X) | 3.634 | 3.751 | 4.206 | 2.077 | 1.746 |
| 速動比率 (X) | 3.051 | 3.239 | 3.746 | 1.525 | 1.411 |
| 資產負債率 (%) | 20.360 | 17.519 | 17.999 | 26.101 | 30.905 |
| 帶息債務/全部投入資本 (%) | 3.880 | 0.263 | 1.182 | 0.039 | -0.684 |
| 股東權益/帶息債務 (%) | 2,423.950 | 37,055.882 | 8,176.952 | 246,499.927 | -14,036.701 |
| 股東權益/負債合計 (%) | 391.163 | 470.820 | 455.593 | 283.132 | 223.572 |
| 利息保障倍數 (X) | -24.779 | -14.804 | -60.142 | 163.212 | 89.785 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 46.820 | 43.883 | 45.020 | 38.991 | 46.642 |
| 存貨周轉天數 (天) | 115.866 | 99.708 | 112.181 | 114.250 | 99.476 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
